Pharmacokinetics and pharmacokinetic-pharmacodynamic relationships of monoclonal antibodies in children.
about
Bevacizumab dosing strategy in paediatric cancer patients based on population pharmacokinetic analysis with external validation.Potential Sources of Inter-Subject Variability in Monoclonal Antibody Pharmacokinetics.Drug Development of Therapeutic Monoclonal Antibodies.The underlying inflammatory chronic disease influences infliximab pharmacokinetics.Drug-Induced Liver Injury in Children: Clinical Observations, Animal Models, and Regulatory Status.
P2860
Pharmacokinetics and pharmacokinetic-pharmacodynamic relationships of monoclonal antibodies in children.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Pharmacokinetics and pharmacok ...... clonal antibodies in children.
@en
type
label
Pharmacokinetics and pharmacok ...... clonal antibodies in children.
@en
prefLabel
Pharmacokinetics and pharmacok ...... clonal antibodies in children.
@en
P2860
P1476
Pharmacokinetics and pharmacok ...... clonal antibodies in children.
@en
P2093
Charlotte Kloft
Johanna Melin
P2860
P2888
P356
10.1007/S40262-014-0208-4
P577
2015-01-01T00:00:00Z
P5875
P6179
1001082655